Journal of Medical Economics
Volume 27, 2024 - Issue 1
Open access
1,053
Views
0
CrossRef citations to date
0
Altmetric
Oncology
Adverse events and costs among non-metastatic castration-resistant prostate cancer patients
Sreevalsa Appukkuttana Bayer HealthCare Pharmaceuticals Inc, Whippany, NJ, USACorrespondence[email protected]
View further author information
, View further author information
Jianying Yaoa Bayer HealthCare Pharmaceuticals Inc, Whippany, NJ, USAView further author information
, Jamie Partridgea Bayer HealthCare Pharmaceuticals Inc, Whippany, NJ, USAView further author information
, Sheldon X. Konga Bayer HealthCare Pharmaceuticals Inc, Whippany, NJ, USAView further author information
, Jacqueline Parkina Bayer HealthCare Pharmaceuticals Inc, Whippany, NJ, USAView further author information
& Stephen J. Freedlandb Cedar-Sinai Medical Center, Los Angeles, CA, USA;c Durham VA Medical Center, Durham, NC, USAView further author information
Pages 145-152
|
Received 02 Nov 2023, Accepted 21 Dec 2023, Published online: 08 Jan 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.